**
Emerging research from Mount Sinai has revealed that fetuses may be exposed to significantly higher levels of PFAS, commonly referred to as “forever chemicals,” than previously understood. This study, which analysed umbilical cord blood samples, identified a total of 42 different PFAS compounds, raising critical concerns about the implications for fetal health during a vulnerable developmental period.
Unveiling the PFAS Landscape
Traditionally, testing of umbilical cord blood has focused on a limited number of PFAS compounds, such as PFOA and PFOS. However, the recent investigation adopted a novel “non-targeted analysis” approach, enabling researchers to uncover a broader spectrum of PFAS. Out of 120 samples tested, the study detected a total of 42 compounds, significantly increasing the estimated levels of these chemicals in fetal blood.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and a co-author of the study, emphasised the importance of these findings. “Babies are exposed to many more PFAS than we previously thought,” she noted, underscoring the potential risks during this critical stage of development.
The Health Risks of PFAS Exposure
PFAS encompass a vast class of approximately 15,000 compounds, renowned for their water-, stain-, and grease-resistant properties. However, these chemicals have been linked to a myriad of serious health issues, including cancer, birth defects, diminished immunity, elevated cholesterol levels, and kidney disease. They are termed “forever chemicals” due to their persistence in the environment, resisting natural breakdown.
A comprehensive review encompassing 40 studies revealed that PFAS have been detected in 30,000 umbilical cord blood samples, indicating widespread exposure. Elevated levels of PFAS in pregnant individuals have been correlated with adverse outcomes such as increased infant mortality, low birth weight, and obesity in later stages of life. Furthermore, fetal exposure to these chemicals has been associated with long-term health issues, including cancer, neurological disorders, and cardiovascular diseases.
Regulatory Gaps and Future Implications
Historically, the most prevalent PFAS compounds, including PFOA and PFOS, were phased out in the last decade, replaced by newer variants that manufacturers claim are less toxic—often without substantial evidence. The challenge lies in regulatory bodies, such as the US Environmental Protection Agency (EPA), which have struggled to keep pace with the expanding array of PFAS compounds. Current testing methods employed by the EPA typically assess only 30 to 40 compounds, leaving a significant gap in monitoring efforts.
The Mount Sinai study highlighted the disparity between conventional testing and the more comprehensive non-targeted approach. While the EPA has recently approved a blood test for 53 compounds, the Mount Sinai analysis identified 31 additional compounds not included in the EPA’s testing protocol.
The Need for Comprehensive Research
Although the Mount Sinai study does not directly link the identified PFAS levels to specific health outcomes, higher concentrations of these chemicals generally correlate with increased health risks. The blood samples analysed were part of the federal government’s Home Study, which tracks PFAS exposure and associated health outcomes over time. Future research efforts are likely to focus on clarifying the health implications of these findings.
David Andrews, acting chief science officer at the Environmental Working Group, which did not participate in the study, remarked on the broader implications of these findings. “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS,” he stated.
Why it Matters
The findings from Mount Sinai serve as a wake-up call regarding the pervasive nature of PFAS contamination in fetal blood. As research continues to uncover the true extent of exposure and its potential health ramifications, it underscores the urgent need for enhanced regulatory measures and a proactive approach to safeguarding public health. The implications for future generations are significant, making it essential to prioritise both scientific inquiry and policy reform to mitigate this persistent environmental threat.
